Related Experiment Video

Updated: Nov 3, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.9K

Pharmacoeconomics in Africa: needs, prospect and challenges

Temitope Ben-Ajepe1, Ifechukwu Benedict Nwogu2, Damilola Quazeem Olaoye3

  • 1Dora Akunyili College of Pharmacy, Igbinedion University, Okada, Edo, Nigeria.

Journal of Pharmaceutical Policy and Practice
|June 1, 2021
PubMed

Insights

Pharmacoeconomics can optimize scarce healthcare resources in Africa, improving medication access and patient outcomes despite rising costs and disease burdens. This approach enhances efficiency and quality of life.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • African Healthcare Systems

Background:

  • Rising healthcare costs and increasing demand in Africa strain resources.
  • Preventable diseases cause significant mortality, exacerbated by inequitable drug distribution.
  • Limited resources necessitate efficient healthcare management strategies.

Discussion:

  • Pharmacoeconomics offers principles for efficient resource allocation in medication selection, procurement, and donation.
  • It guides policy decisions for population prioritization and health insurance schemes.
  • Tools assess interventions based on quality of life improvements.

Key Insights:

  • Implementing pharmacoeconomics is crucial for maximizing healthcare benefits in Africa.
  • Efficient resource utilization can mitigate the impact of poverty on health outcomes.
  • Quality of life metrics are vital for evaluating therapeutic choices.

Outlook:

  • Africa needs to adopt pharmacoeconomic strategies to address its healthcare challenges.
  • Prospects include improved drug access and cost-effective healthcare solutions.
  • Challenges involve data scarcity and capacity building for effective implementation.

Keywords:
AfricaChallengesNeedsPharmacoeconomicsProspect

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
43
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
506
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
333
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
57
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.5K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K